Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques

Cherie T. Ng, J. Pablo Jaworski, Pushpa Jayaraman, William F. Sutton, Patrick Delio, Larene Kuller, David Anderson, Gary Landucci, Barbra A. Richardson, Dennis R. Burton, Donald N. Forthal, Nancy L. Haigwood

Research output: Contribution to journalArticlepeer-review

125 Scopus citations

Abstract

Maternal HIV-1-specific antibodies are efficiently transferred to newborns, but their role in disease control is unknown. We administered neutralizing IgG, including the human neutralizing monoclonal IgG1b12, at levels insufficient to block infection, to six newborn macaques before oral challenge with simian-HIV strain SF162P3 (SHIVSF162P3). All of the macaques rapidly developed neutralizing antibodies and had significantly reduced plasma viremia for six months. These studies support the use of neutralizing antibodies in enhancing B cell responses and viral control in perinatal settings.

Original languageEnglish (US)
Pages (from-to)1117-1119
Number of pages3
JournalNature medicine
Volume16
Issue number10
DOIs
StatePublished - Oct 2010

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques'. Together they form a unique fingerprint.

Cite this